Investment in Equity Securities
|12 Months Ended|
Sep. 30, 2018
|Investments, Debt and Equity Securities [Abstract]|
|Investment in Equity Securities||
NOTE 5 - INVESTMENT IN EQUITY SECURITIES
As of September 30, 2018 the Company held one million (1,000,000) common stock of Amarantus BioScience Holdings, Inc. (AMBS) with a fair value of $33,800.
The entire disclosure for investments in certain debt and equity securities.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef